DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gish RG et al.
Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.
J Clin Oncol 2007;
25 (21) 3069-3075
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.